Clinical Trial Update: Adjuvant Chemotherapy With FOLFOX in HCC Patients After Resection [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating adjuvant FOLFOX chemotherapy after surgical resection in hepatocellular carcinoma patients; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• FLUOROURACIL (Fluorouracil)
• Leucovorin (folinic acid)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Carcinoma, Hepatocellular | Phase 3 | Status: UNKNOWN